In January 2022, just 2.8% of Tanzania was vaccinated against COVID-19. A year and a half later, the majority of Tanzanians have completed their “primary series.” VaccinesWork asked experts what made all the difference.

Guinea has suffered outbreaks of Ebola, measles, Lassa Fever and Marburg, as well as COVID-19, over the past decade. VaccinesWork spoke to Gavi’s Senior Country Manager, Magdi Ibrahim, about how the country is learning from a troubled recent past…

Twelve countries across different regions in Africa are set to receive 18 million doses of the first-ever malaria vaccine over the next two years.

Thousands of villagers in Mugum Karmarong Rural Muncipality have benefitted from Bali Raj Budha’s weekend outreaches.

The pandemic, war in Ukraine and other crises have left UN poverty, hunger and health goals off track.

To head-off a new spillover, scientists are combining a menagerie of animals, AI-driven models, and open communication.

A vaccine that protects dogs against fatal fungal infections is set to launch in 2024. As more fungi become resistant to treatment, could urgently needed human vaccines follow?

The pandemic meant several new Gavi vaccine programmes in lower-income countries had to be paused. Following a Board decision this week, these programmes are back on. 

Gavi’s Board approved new investments in six-in-one (hexavalent) vaccine and approved a long list of potential new vaccines for consideration for inclusion in future Gavi programmes at its Board Meeting, which concluded today 

UNICEF expects WHO prequalification of the first whole-cell pertussis hexavalent vaccine during the third quarter of 2023. Here’s how they differ from existing vaccines.

Urban populations are diverse, and certain neighbourhoods or subgroups may be disproportionately affected by poor birth outcomes.

Primary health care systems must become more resilient as the effects of climate change worsen.